News Release

Association of use of ACEI, ARB with testing positive for COVID-19

Peer-Reviewed Publication

JAMA Network

What The Study Did: This observational study assessed the association between the use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with the likelihood of testing positive for coronavirus disease 2019 (COVID-19).

Authors: Ankur Kalra, M.D., of the Cleveland Clinic in Akron, Ohio, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link 


Editor's Note: The article contains conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.


Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.